Radiodermatitis also known as radiation induced skin reaction or radiation injury is a side effect of ionizing radiation on the skin due to exposure to radiation during cancer treatment, or radiation treatment of skin. Increasing number of cancer patients has significantly increased the adoption of radiation-based therapy.
According to the American Society for Radiation Oncology, among the patients receiving radiation therapy for treatment of cancer, approximately 95% of the patients are affected with some degree of radiodermatitis. This has surged the demand for radiodermatitis treatment procedures and medication around the globe.
Increasing use of radiation-based equipment in medical aesthetics has contributed significantly in the rise of radiodermatitis. The effects of radiations used during medical aesthetic procedures takes significant time to show impact on the skin. The global radiodermatitis market is anticipated to witness significant growth during the forecast period.
North America contributed the largest share to the global radiodermatitis market in 2019 owing to high volume of cancer patients undergoing radiotherapy treatment. High prevalence of cancer and rising penetration of medical aesthetic procedures is anticipated to bolster the growth of North America radiodermatitis market during forecast period.
Asia Pacific is anticipated to be the fastest growing market during the forecast period owing to increasing number of cancer patients, growth of cancer treatments, and rising medical tourism. Increasing investment in the development and expansion of pharmaceutical manufacturing in China, India, and Indonesia is anticipated to contribute towards the growth of radiodermatitis market in Asia Pacific during the forecast period 2022-2032.
The report titled “Radiodermatitis Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global radiodermatitis market.
The report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global radiodermatitis market is segmented based on product type, sales channel, and geography. Based on product type, the global radiodermatitis market is segmented into topical products, oral products, and dressings. The topical products are sub-segmented into corticosteroids, hydrophilic creams, antibiotics, and others. The dressings are sub-segmented into hydrogel & hydrocolloid dressings, no sting barrier films, honey impregnated gauze, silicone coated dressings, and others. Based on sales channel, the global radiodermatitis market is segmented into hospital, and pharmacies. Based on geography, the global radiodermatitis market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on radiodermatitis products. Further, market share of prominent companies in the global radiodermatitis market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the radiodermatitis product manufacturing companies. Furthermore, the global radiodermatitis market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution.
Product portfolio would focus on all the products under the radiodermatitis business segment of the company. Similarly, the recent development section would focus on the developments of companies such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion.
Major players active in the global radiodermatitis market include Acelity L.P. Inc., Alliqua BioMedical, Inc., BMG Pharma S.R.L., ConvaTec Inc., Derma Sciences Inc., Molnlycke Health Care AB, Smith & Nephew, Stratpharma AG, and 3M Company.
By Product Type
By Sales Channel
The Radiodermatitis market has been assessed for the years 2019 to 2032.
North America contributed the largest share to the global radiodermatitis market.
Key Radiodermatitis market players are Acelity L.P. Inc., Alliqua BioMedical, Inc., BMG Pharma S.R.L., ConvaTec Inc., Derma Sciences Inc., Molnlycke Health Care AB, Smith & Nephew and others.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved